fbpx
May 17, 2024

Day: July 25, 2017

1 min read

Published on: July 21, 2017 at 12:00PM Condition:   Non-Small Cell Lung CancerInterventions:   Drug: ALT-803 + Pembrolizumab;   Drug: ALT-803 + NivolumabSponsor:   Altor Bioscience CorporationNot yet recruiting - verified...

1 min read

Published on: July 24, 2017 at 12:00PM Conditions:   Stage I Pleural Malignant Mesothelioma AJCC v7;   Stage IA Pleural Malignant Mesothelioma AJCC v7;   Stage IB Pleural Malignant Mesothelioma AJCC v7;   Stage II Pleural Malignant Mesothelioma AJCC v7;   Stage III Pleural Malignant Mesothelioma AJCC v7Interventions:   Drug: Atezolizumab;...

%d bloggers like this: